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Introduction
Fluorescence in situ hybridization (FISH) is increasingly being applied to detect chromosome anomalies in metaphase and interphase cells in a variety of hematologic malignancies. The Philadelphia (Ph) translocation t(9;22)(q34;q11) represents the cytogenetic hallmark of chronic myeloid leukemia (CML), and occurs also in about 25% of adults with acute lymphoblastic leukemia (ALL). [1] [2] [3] [4] [5] The t(9;22) leads to the fusion of a part of the ABL gene on chromosome 9q34 with part of the BCR gene on 22q11. In ALL, the breakpoint in BCR may be located either in the major breakpoint cluster region (M-BCR) which is commonly rearranged in CML, or in the minor breakpoint cluster region (m-BCR) located centromeric to M-BCR. The fusion genes encode for mRNA species of 8.5 and 7.0 kb size, respectively, which form the basis of the molecular detection of the Ph translocation by polymerase chain reaction analysis (RT-PCR). [6] [7] [8] [9] [10] [11] [12] Using FISH with probes for the ABL and BCR genes labelled with different fluorochromes, respectively, the BCR/ABL fusion gene is indicated through the colocalization of a BCR and an ABL hybridization signal. This approach has been used successfully to detect the Ph translocation in metaphase chromosomes, as well as in interphase nuclei of Phpositive CML and ALL patients.
13-16 ALL patients carrying a Ph translocation have a most dismal prognosis and are subjected to high risk treatment protocols. 1, [3] [4] [5] 12, [17] [18] [19] Therefore, the unambiguous identification of these patients is mandatory. Conventional chromosome analysis allows for unequivocal diagnosis of Ph-positive ALL if a standard Ph translocation t(9;22) is present. Variant Ph translocations, which may occur in 3% of the Ph-positive ALL patients, may leave the diagnosis ambiguous with respect to the classical gene rearrangement without further molecular genetic or molecular cytogenetic investigations. 20 The high value of FISH analysis with ABL and BCR probes in the initial diagnosis and for the detection of residual disease in CML patients has been demonstrated in several studies. [14] [15] [16] [21] [22] [23] [24] [25] [26] [27] [28] In ALL, the applicability of FISH to detect the BCR/ABL rearrangement has only been addressed in small series of selected patients and in single cases with variant Ph translocations. 15, 16, 20, 29, 30 Using FISH on interphase nuclei, a colocalization of a BCR and ABL hybridization spot may occur by chance due to the two-dimensional projection of the BCR and ABL hybridization signals of the three-dimensional nucleus, and thus lead to a false positive result. Therefore, a cut-off rate for false positive nuclei has to be determined for the respective FISH procedure. 31, 32 However, the accuracy of the FISH diagnosis of the Ph translocation may also depend on the sensitivity of the respective FISH protocol. So far, no data are available concerning the proportion of false negative nuclei in BCR/ABL FISH investigations in bone marrow and/or peripheral blood samples of Ph-positive ALL patients.
We performed a prospective dual-color FISH study in 104 adult patients with ALL using ABL and BCR probes. The results were compared with chromosome and RT-PCR findings to evaluate the applicability and specificity for the detection of the Ph translocation and of other chromosome changes involving ABL and/or BCR. The proportion of false-negative cells in ALL samples produced by the FISH procedure was estimated using supernumerary BCR and/or ABL loci as internal controls in patients with a Ph translocation and additional aberrations, eg with an extra Ph chromosome, an isochromosome i(9)(q10), or trisomy 9.
Materials and methods

Controls and patients
Three healthy volunteers and 17 Ph-negative adult ALL patients served as controls. The patients included four cases with a t(4;11), one case with a t(8;22)(q24;q11), one case with low hypodiploid (35 chromosomes), five cases with high hyperdiploid (51-68 chromosomes), four cases with near triploid, and two cases with near tetraploid karyotypes.
One hundred and four adult patients with ALL aged 15-79.5 years (median 39.9) were studied prospectively at initial diagnosis in context of the German Multicenter Adult ALL trial (GMALL 05/93). All cases were investigated by conventional chromosome banding and FISH. RT-PCR analyses were done in patients with B cell precursor ALL. Classical cytogenetic, FISH and molecular genetic investigators were blinded to the results of each of the other methods.
Chromosome analysis
Bone marrow (BM) and/or peripheral blood (PB) samples were sent in by overnight mail. Classical cytogenetic analysis was performed using standard procedures. Chromosomes were identified using a modified G-banding technique, and described according to the International System for Human Cytogenetic Nomenclature (ISCN). 33, 34 Patients were diagnosed Ph-positive if a translocation t(9;22)(q34;q11) was visible. Cases with a 22q−, but without an obvious 9q+ chromosome as well as cases lacking metaphases, were classified as non-conclusive.
Dual-color fluorescence in situ hybridization (FISH)
FISH was performed using fixed cells of the cytogenetic preparations. Commercially available probes for BCR covering approximately 300 kb immediatedly 5Ј of the major breakpoint region and for ABL covering approximately 200 kb 3Ј of exon VI, readily labelled with SpectrumOrange (ABL) and SpectrumGreen (BCR) (Vysis, Downer's Grove, IL, USA), as well as a biotin-labelled chromosome 9 paint probe (Oncor, Gaithersburg, MD, USA) were used. 35 The probes were hybridized essentially as described. 36 Briefly, fixed cells were dropped on to slides the day before and air dried. The slides were rehydrated in 100%, 70%, 50% and 30% ethanol for 1 min each, passed through 0.1 SSC and 2 × SSC for 2 min each at room temperature (RT), and incubated in 70°C 2 × SSC for 30 min. The slides were washed in 0.1 × SSC for 1 min and denatured in 0.07 N NaOH for 1 min at RT, washed in chilled 0.1 × SSC, dehydrated in 30%, 50%, 70% and 100% ethanol for 1 min each and air dried. Denaturation and application of the probe mixtures, as well as overnight hybridization were done according to the manufacturer's instructions. After hybridization, the slides were washed in 1 × SSC at 74°C for 5 min, stained in 4,6-diamidino-2-phenylindol (DAPI), and mounted (Vectashield; Vector Laboratories, Burlingame, CA, USA). The biotin-labelled probe was detected using FITC conjugated streptavidine prior to DAPI staining as described. 37 The FISH signals were analyzed on a Zeiss Axiophot epifluorescence microscope (Zeiss, Oberkochem, Germany) equipped with a 50 W mercury lamp and filter combination No. 1 according to Prof Pinkel (AHF Analysentechnik, Tü bingen, Germany). Yellow fusion signals of red and green fluorescence were visualized by a FITC/Texas Red-rhodamine dual band excitation filter. FISH findings were described according to ISCN. 34 All FISH analyses were done by a single investigator.
The evaluation of 200 nuclei was attempted in each patient. Cases were included in this study if at least 100 cells were analyzed. The number and the colocalization of the red ABL and of the green BCR hybridization signals were determined in each nucleus. A colocalization of the red and green fluorescences was recorded if a yellow fusion signal was observed. The proportion of cells with colocalized signals was calculated on the basis of the total number of nuclei analyzed in each patient.
The rate of false-negative BCR/ABL FISH signals was investigated in Ph-positive patients with additional chromosome aberrations resulting in gain of BCR and/or ABL loci ( Figure  1 ). An extra Ph chromosome leads to three spots of each, BCR and ABL, with two BCR/ABL fusion signals. Gain of the long arm of chromosome 9 in Ph-positive cells due to an isochromome i(9)(q10) or a trisomy 9 results in three ABL and two BCR spots, of which one BCR and one ABL signal are expected to show a colocalization. In three patients with two Ph chromosomes the proportion of nuclei with three signals of each, BCR and ABL, and with two, one, or no fusion signals was determined. In three patients, two with an i(9)(q10) and one with a trisomy 9, nuclei with three ABL and two BCR signals were evaluated with respect to the presence or absence of a BCR/ABL fusion signal. At least 100 nuclei were analyzed in each case. Nuclei were assigned false negative if they did not show the expected pattern of fusion signals.
RT-PCR
The fusion of the BCR and ABL genes was investigated on the mRNA level simultaneously in two institutions using the polymerase chain reaction after a reverse-transcriptase step (RT-PCR) by a nested primer approach as described. 12, 38 Data of all patients reported here were matched between both laboratories. A patient was considered BCR/ABL positive if the molecular rearrangement was detected in both laboratories independently. Patients lacking matched results were classified as non-conclusive.
Cytological and immunological analysis
The morphological appearance of blasts on smears of bone marrow and peripheral blood was classified according to the FAB criteria. 39, 40 Immunological analyses were performed as described. [41] [42] [43] Immunophenotypic subgroups of ALL were defined as follows: pro-B-ALL (CD19+, CD24+/−, CD10−, cylgM−), common-ALL (CD19+, CD10+, cylgM−), pre-B-ALL (CD19+, CD10+/−, cylgM+, slgm−) or mature B-ALL (CD19+, CD10+/−, cylgM−/+, slgM+), and T-lineage ALL as pre-T-ALL (cyCD3+, CD5+, CD7+, CD2−) or T-ALL (CD5+, CD7+, CD2+, CD1+/−).
Results
Determination of the cut-off values and estimation of the proportion of false-negative nuclei of the FISH procedure
The hybridization efficiency was determined in three healthy volunteers and in five ALL cases, four with t(4;11) and 1 with t (8;22) . Two hybridization signals of ABL and BCR were found in 98.1 ± 0.4% and 98.0 ± 0.9%, one spot in 1.5 ± 1.1 and 1.7 ± 0.3%, and three spots in 0.5 ± 0.7% and 0.2 ± 0.5%, respectively. This indicated a very high efficiency of the hybridization procedure. A mean rate of fusion signals of 2.9 ± 0.9% was found in the nuclei of three healthy controls and 17 ALL patients without a Ph translocation. Thus, the cut-off value for false-positive nuclei was set at 6% (mean, plus 3 × s.d.). However, the mean rate of fusion signals was lower (2.2 ± 0.6%) in 11 cases with high hyperdiploid, near triploid, or near tetraploid karyotypes when compared to six cases with hypodiploid, normal diploid or pseudodiploid karyotypes (3.7 ± 0.5). In seven of the controls gain of BCR and/or ABL loci were present. Fusion signal rates ranged from 1.2-3.1% in these cases.
The proportion of Ph-positive cells with a false-negative BCR/ABL fusion signal was investigated in six Ph-positive patients diagnosed previously with gain of BCR and/or ABL loci, three with an additional Ph chromosome, two with i(9)(q10) and one with trisomy 9. In three cases with an additional Ph chromosome, 3.8-21.7% of the nuclei with three BCR and ABL signals showed only one or no BCR/ABL fusion signal, and in three cases with i(9q) or trisomy 9, 1.5-12.5% of the nuclei with three ABL and two BCR signals did not show a BCR/ABL fusion signal (mean 12.1 ± 8.6%). (Table 1) .
Prospective study
A series of 104 adult ALL patients was screened prospectively by FISH for the BCR/ABL rearrangement, including six patients with pro-B-ALL, 48 with common-ALL, eight with pre-B-ALL, eight with B-ALL, five with pre-T-ALL, 20 with T-ALL, and nine without immunological diagnosis. In 87 cases у200 nuclei were analyzed. In 17 patients, due to shortcomings of fixed cells, only 100-199 nuclei were evaluated. In 76 patients, BCR/ABL fusion signals were below the cut-off level of 6% and ranged from 0.4-5.5% (3.0 ± 1.2%). In 28 cases, 7.1-97.4% of the nuclei showed colocalizations of BCR and ABL (56.2 ± 31.2%) indicating a Ph translocation ( Figure 2 , Table  2 ). Conventional cytogenetic results were obtained in 101 patients (97.1%), and in 19 cases a Ph translocation was identified. A derivative chromosome 22 suggesting a Ph chromosome without clear evidence of a derivative 9q+ chromosome was found in three additional cases. The BCR/ABL rearrangement was investigated by RT-PCR in 54 patients. No Ph translocation was found in 32 cases, 13 demonstrated a rearrangement in m-BCR, and six in M-BCR. One patient showed concurrent M-BCR and m-BCR transcripts. In two cases, no molecular diagnosis was made because both molecular genetic reference laboratories did not obtain matched results.
In none of the 76 patients classified as Ph-negative by FISH a Ph translocation was found by conventional cytogenetics or PCR (Tables 3 and 4 ). However, in one of these cases a derivative chromosome 22 suggesting a Ph chromosome was present (Table 5 , case 3). The FISH diagnosis of a BCR/ABL rearrangement was confirmed by chromosome analysis and/or PCR in 24 of 28 patients, of which two presented with one or two 22q−, but without clear 9q+ chromosomes (Table 5 , cases 12 and 16). The rate of fusion signals ranged from 12.6-97.5% in these cases (mean 64.1 ± 26.2%). The remaining four patients showed moderately increased BCR/ABL fusion rates of 7.2% to 11.5%. Two of these patients presented with common-ALL, high hyperdiploid karyotypes, and lack of the chimeric BCR/ABL transcript by PCR (Table 5 , cases 6 and 7). Both patients exhibited three BCR spots and further gain of an ABL or a BCR signal in a subclone. In the latter case, chromosome analysis and FISH on metaphase chromosomes revealed a partial trisomy 9q due to an unbalanced translocation der(17)t(9;17)(q1?1;p1?), and gain of a chromosome 22. In both cases, the BCR/ABL fusion signal rate was increased in nuclei with additional BCR and/or ABL signals, only (Table 6 ).
Both remaining patients had a CD1+ T-ALL and lacked cytogenetic evidence of a Ph translocation (Table 5 , cases 8 and 9). Overall, false positive results were obtained by FISH in four of 80 cases (5%).
Low increased rates of BCR/ABL fusion signals (Ͻ18%) were found in two cases which were Ph-positive by PCR and/or chromosome analysis (Table 5 , cases 10 and 11). FISH had been performed on fixed cells of 72 h bone marrow cell culture in one, and of 24 h peripheral blood cell culture in the other.
Fifty-four cases were investigated by FISH, conventional cytogenetics and RT-PCR (Table 4) . Two cases (3.7%) with a Ph translocation as indicated by FISH were Ph-negative by chromosome analysis and PCR. In four cases (7.4%) with a Ph translocation diagnosed by FISH and PCR, chromosome analysis demonstrated a derivative chromosome 22 in one, normal karyotypes in two, and lack of metaphases in one patient. PCR analysis was BCR/ABL-negative in one case which was Ph-positive according to conventional cytogenetics and FISH (1.9%). No conclusive PCR diagnosis was made in two cases (3.7%). The combination of two methods revealed no consistent diagnoses in five cases (9.3%) when PCR and FISH were applied (Table 5 , cases 2, 5-7, 10), in six patients (11.1%) when chromosome analysis and FISH (Table 5, 
Figure 2
Proportion of nuclei with BCR/ABL fusion signals in 104 adult ALL patients without (outlined bars) and with (filled bars) Ph translocation by chromosome (presence of 9q+ and 22q− chromosomes) and/or PCR analyses (BCR/ABL rearrangement in two independent assays) in increasing order. The cut-off limit for false positive nuclei is indicated. In 12 (11.5%) cases, FISH detected gain of BCR and/or ABL loci. An additional BCR signal was observed in one patient with normal, and in one case with high hyperdiploid metaphases. In the latter, a subclone with four copies of BCR was present. A supernumerary ABL signal was found in one case lacking cytogenetic data and in one patient with an isochromosome i(9)(q10). In the latter patient, a terminal deletion of the long arm of the homologous chromosome 9 was present in 12 out of 24 metaphases with an i(9q) which resulted in loss of one ABL allele (Figures 3 and 4) . Thus, some of the nuclei of this patient which exhibited only two ABL spots may also carry an i(9)(q10) together with a deletion of the long arm of the homologous chromosome 9. Three BCR and ABL spots were found in three patients. Two of them presented with high hyperdiploid karyotypes, complete or partial trisomy 9, and gain of chromosome 22, one had T-ALL and a constitutional pericentric inversion of chromosome 16. In summary, in seven of 80 (8.8%) ALL patients without a Ph translocation FISH revealed an abnormal karyotype which in three cases had not been detected by conventional cytogenetics. In five Ph or BCR/ABL-positive patients gain of BCR and ABL loci producing a second fusion signal was found. This was consistent with an extra Ph chromosome in four of these patients. One case showed only normal metaphases.
Discussion
We studied the reliability of dual-color FISH with probes for BCR and ABL in a prospective series of 104 adult patients with ALL. FISH identified a BCR/ABL rearrangement in all 24 patients in which the Ph translocation was diagnosed by chromosome analysis and/or PCR. This indicated a high sensitivity of the FISH procedure of 100%. However, in two patients with common-ALL, high hyperdiploid karyotypes, and gains of BCR and/or ABL loci, a low increase of BCR/ABL fusion signals suggested a Ph translocation which was neither confirmed by 
CA, conventional chromosome analysis; −, Ph-negative; +, Ph-positive; number in brackets, number of cases with non-conclusive results. a Table 5 , cases 6-9, 12-16. b Table 5 , cases 6, 7, 10. c Table 5 , case 10. d Table 5 , cases 12-15. BM, bone marrow; PB, peripheral blood; FISH, fluorescence in situ hybridization; common, common-ALL; pre-B, pre-B-ALL; T, T-ALL; -, not investigated; NC, non-conclusive; NR, not rearranged; M-BCR, major breakpoint cluster region; m-BCR, minor breakpoint cluster region.
Table 6
Proportion of BCR/ABL fusion signal counts in two Phnegative patients with gain of BCR and/or ABL loci 
Figure 3
Karyogram of a patient with common-ALL demonstrating an isochromosome, i(9)(q10) (open arrow), and a terminal deletion of the long arm of the homologous chromosome 9, del(9)(q22) (filled arrow).
Figure 4
Partial karyotypes of the case presented in Figure 3 hybridized with chromosome 9 paint (green) and ABL (red, arrows) probes. (A) Three ABL loci are present due to an i(9)(q10) and one normal chromosome 9. (B) Two ABL loci are present due to an i(9)(q10) and a deletion of the ABL gene of the homologous chromosome 9.
chromosome analysis nor by PCR. In controls with gains of BCR and/or ABL loci no augmented rate of fusion signals was found. However, because in both cases the increased fusion signal rate was attributable to nuclei with extra copies of BCR and/or ABL, the amplification of the number of FISH target sequences may have contributed to the augmented fusion signal rate by adding to the chance of an accidental colocalization of the FISH spots in both cases. Therefore, apart from the scoring of the colocalization signals, the detailed recording of the hybridization spot distribution may be recommended in dual-color BCR/ABL FISH analyses to uncover the false positive FISH diagnosis of a non-existent Ph translocation due to gain of target loci. Two additional cases with T-ALL presented with a low increase of BCR/ABL fusion signals indicating a Ph translocation which was not confirmed by cytogenetics. Blast cells with highly condensed chromatin have been described in CD1+ T-ALL. 44 The association of an increase of false positive results with decreasing size of the nuclei has been demonstrated in dual-color BCR/ABL FISH. 35 Therefore, the augmented BCR/ABL fusion signal rate in both CD1+ T-ALL patients may be due to the presence of a high proportion of cells with small nuclei. Overall, the false positive rate of the FISH analysis was 5% in this series. Lack of false positive results has been reported in cases with a normal BCR and ABL set using dual-color FISH with ABL and breakpoint spanning BCR probes or a triple-probe three-colour FISH system. 16, 45 However, changes of the BCR/ABL FISH target copy number, as well as small nuclei sizes, may affect the specificity of these BCR/ABL FISH techniques in ALL, too. Their value for the diagnosis of the Ph translocation in ALL awaits a prospective study.
False negative nuclei were identified in 1.5-22% of the cells from Ph-positive patients, using additional chromosome aberrations as internal controls which resulted in gain of BCR and/or ABL loci. In the Ph translocation, the genomic break of the ABL gene may occur within a 200 kb region. Therefore, depending on the ABL breakpoint position, the genomic distance of the BCR and ABL FISH probes in the Ph chromosome may vary from 30-230 kb. In a study using the same FISH probes and similar evaluation criteria as applied by us, a large genomic distance between the BCR and ABL probes was associated with an increased rate of false negative nuclei of 35-45% of the cells in Ph-positive CML patients. Moreover, an increase of the nucleus size was associated with an augmented proportion of false negative nuclei of up to 20% of the cells in a Ph-positive ALL cell line. 25 Cell and nuclei sizes vary widely within ALL, and ABL breakpoints are scattered over a large region in Ph-positive ALL as well. 39, 40, 44, 46 Therefore, high rates of false negative nuclei in our study may also be due to augmented nuclei sizes and/or increased genomic distances between the BCR and ABL FISH probes in the Ph chromosomes.
None of the 76 patients diagnosed Ph-negative by FISH was Ph-positive by chromosome analysis or PCR in this series. However, a low increase of a BCR/ABL fusion signal rate as small as 12.6% was found in Ph-positive patients. Even a rate of FISH-positive nuclei within that of normal control samples has been described in a case with ALL and cytogenetic evidence of a Ph translocation. 15 False negative nuclei as well as low blast cell counts may have contributed to the low rate of BCR/ABL fusion signals in these Ph-positive patients. In our series, the leukemic cell contents of the cytogenetic preparations used for FISH were not determined. However, low fusion signal rates were found in peripheral blood cells after 24 h cultivation or in bone marrow cells after 72 h cultivation in two of our cases. Blast cell counts may be lower in peripheral blood than in bone marrow samples. Moreover, ALL blasts may undergo apoptosis during cultivation, whereas normal hematopoietic cells survive longer. [47] [48] [49] [50] Therefore, the detection rate of Ph-positive cells may be improved by using uncultivated bone marrow samples for FISH analysis in ALL.
In our series of 54 patients with combined FISH, PCR, and chromosome analyses, each method failed to establish a correct diagnosis in two (3.7%; FISH), three (5.6%; PCR), or four (7.4%; classical cytogenetics) cases. In studies of ALL patients with normal karyotypes or failed cytogenetics, 0-22.2% exhibited BCR/ABL rearrangements in the PCR analysis. 38, 51, 52 No BCR/ABL rearrangement was detected by PCR in two of eight, and in two of 47 ALL patients with cytogenetic presentation of a Ph translocation. 20, 53 Only small numbers of selected ALL patients have been studied by BCR/ABL FISH, so far. Using different methods, FISH identified a BCR/ABL rearrangement in four of five, 15 and in all 11 selected ALL patients with a Ph translocation by cytogenetics and/or PCR. 16, 22 In the light of the results from our series, neither classical cytogenetics, nor PCR or FISH have proven to represent a stand-alone technique for the reliable identification of Ph-positive ALL patients. Moreover, in this study, the combination of two of the three methods led to discrepant results in five (9.3%; FISH and PCR), six (11.1%; FISH and classical cytogenetics), and seven (13%; classical cytogenetics and PCR) cases. Therefore, three independent methods may be required to establish the correct diagnosis of the BCR/ABL status in such patients. However, due to its high sensitivity dual-color BCR/ABL FISH may efficiently be used to screen for Ph-positive ALL patients. In cases with a low (Ͻ18%) increase of fusion signal rates the BCR/ABL status should be verified by PCR and/or chromosome analyses to prevent false positive diagnosis of a Ph translocation.
In 11.5% of the patients, BCR/ABL FISH disclosed extra copies of BCR and/or ABL. This was due to a duplication of the Ph chromosome in five cases, a typical secondary change in Ph-positive ALL patients. 20, [54] [55] [56] [57] [58] Additional BCR and/or ABL loci were found in seven of 80 (8.8%) Ph-negative ALL patients. This is in accordance with findings from chromosome studies demonstrating the nonrandom involvement of chromosome 9 and/or 22 in numerical changes in ALL. 59, 60 In one patient, three ABL signals were found to be due to an isochromosome i(9)(q10) occurring in about 1% of the ALL patients. [61] [62] [63] However, in a subclone a terminal deletion with loss of the ABL gene of the long arm of the homologous chromosome 9 was present in addition to the i(9q). Nuclei carrying this combination of chromosome aberrations exhibit two ABL apart from two BCR signals and thus escape BCR/ABL FISH detection. This case, on one hand, clearly demonstrates the limitations of the FISH analysis and, on the other, highlights the advantage of the combined use of FISH and metaphase chromosome analyses.
Overall, in this large prospective series BCR/ABL FISH identified chromosome abnormalities including BCR and/or ABL copy number changes in 29.8% of adult ALL patients. It proved to be a highly sensitive tool for the detection of the Ph translocation. However, the possibility of false positive FISH diagnosis of a Ph translocation and of ambiguous test results using only two independent BCR/ABL detection methods was also demonstrated. Therefore, dual-color FISH may be used efficiently for the Ph translocation screening but should be combined with chromosome and/or RT-PCR analyses to establish the BCR/ABL status in adult ALL patients unambiguously.
